In vitro diagnostics (IVD) solutions are medical devices used to analyze biological samples such as urine, blood, and tissue in order to detect infections, diagnose medical conditions as well as monitor drug therapies. They play a significant role in the healthcare industry. Moreover, the IVD range of products includes analytical instruments, chemicals and reagents, disposables, and various data management software that assists the execution of analytical experiments. Furthermore, IVD tests employ a wide range of processes starting from home-based tests; laboratory-developed tests as well as high precision genomic tests.
Healthcare experts have found In Vitro Diagnostic (IVD) Market to be one of the most rapidly evolving markets and the global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030. The market is driven by certain factors, which include rise in adoption of rapid, minimally invasive and non-invasive diagnostics tools & techniques, rise in the global geriatric population, high number of patients with infectious and chronic diseases, rise in the global healthcare expenditure, and rise in the demand for POC testing.
The market is favored by the development of rapid diagnostic instruments and consumables for several clinical areas, such as infectious disease, oncology/cancer, cardiology, HIV/AIDS, and nephrology, among others. Additionally, recent infectious disease outbreaks, such as COVID-19, have further propelled the growth of the global market.
The BIS Research report on the IVD market is primarily segmented on the basis of products types(instrument, consumables, software, and services). The market is also segmented on the basis of test type, application, end user, and region.
Market Segmentation
• Product – Instruments, Consumables, and Software
• Test Type – Immunoassay, Clinical Chemistry, Whole Blood Glucose Monitoring, Molecular Diagnostics, Microbiology, Anatomic Pathology, Hematology, Coagulation, Critical Care, Urinalysis, and Others
• Application- Diabetes, Infectious Disease, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Disease, Drug Testing/Pharmacogenomics, HIV/AIDS, Women Health, and Others
• End User – Hospitals, Central Laboratories, Point-of-Care (POC), Clinics, Academic Institutions, and Others
Regional Segmentation
• North America – U.S., Canada
• Europe – Germany, U.K., France, Italy, Spain, the Netherlands, and Rest-of-Europe
• Asia-Pacific – Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific
• Latin America – Brazil, Mexico, and Rest-of-Latin America
• Middle East – Saudi Arabia, Israel, and Rest-of-Middle East
• Rest-of-the-World
Growth Drivers
• Rise in Adoption of Rapid, Minimally Invasive and Non-Invasive Diagnostics Tools & Techniques
• Rise in the Global Geriatric Population
• High Number of Patients with Infectious and Chronic Diseases
• Rise in the Global Healthcare Expenditure
• Rise in the Demand for POC Testing
Market Challenges
• Uneven Reimbursement Scenario
• Uncertain Regulatory Environment
Market Opportunities
• Rise in the Demand for Molecular Diagnostics
• Epigenomics Based Approach
Key Companies Profiled
Agilent Technologies, Inc., F. Hoffmann-La Roche, Illumina, Inc., Qiagen N.V., Abbott Laboratories, Inc., Thermo Fisher Scientific, Danaher Corporation, Myriad Genetics, Inc., Laboratory Corporation of America Holdings, Siemens Healthineers, Inc., Quest Diagnostics Incorporated, Bio-Rad Laboratories, Inc., Sysmex Corporation, bioMérieux S.A. Becton, Dickinson and Company, Ortho Clinical Diagnostics, Hologic, Inc, and DiaSorin S.p.A.
Competitive Landscape
The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of IVD to increase the accuracy and to ensure shorter turn-around time for disease diagnosis. Due to the diverse product portfolio and intense market penetration, F. Hoffmann-La Roche has been a pioneer in this field and has been a significant competitor in this market.
On the basis of region, North America holds the largest share of the global in vitro diagnostic market due to growing incidence of infectious disease and cancer, including its various types, increased focus on democratizing precision diagnostics for various applications, increasing geriatric population, and favorable government reimbursement policies in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.
Key Questions Answered in this Report:
• What are IVD solutions? How have different IVD solutions evolved over the years?
• What are the major market drivers, challenges, and opportunities in the global IVD market?
• What was the global IVD market size in terms of revenue in 2019? How is the market expected to evolve in the upcoming years? What is the market size expected to be in 2030?
• How is each segment of the global IVD market expected to grow during the forecast period between 2020 to 2030, and what is the revenue expected to be generated by each of the segments by the end of 2030?
• What are the developmental strategies implemented by the key players to sustain in the competitive market?
• What is the growth potential of the IVD market in each region, namely, North America, Europe, Asia-Pacific, Latin America, Middle East, and Rest-of-the-World?
• Which product among the two (assays and kits & instrument) are offered by key players such as Thermo Fisher Scientific, Illumina Inc., Qiagen N.V., and F. Hoffmann-La Roche Ltd.?
• Which test type is leading the market in 2019 and expected to dominate the market in 2030, and why?
• Which application and end user type are leading the market in 2019 and are expected to dominate the market in 2030, and why?
• Which region dominated the global IVD market in 2019, and what are the expected trends from each of the regions during the forecast period 2020-2030?
• What are the emerging trends in the global in vitro diagnostic market?
• Which companies are anticipated to be highly disruptive in the future, and why?
Request a Sample - https://bisresearch.com/requestsample?id=937&type=download
The report comprises an in-depth study of the global IVD market. The study also presents a detailed analysis of the market dynamics and estimation of the market size over the forecast period 2020- 2030.The scope of this report is focused on the analysis of the IVD market on the basis of product, test type, application, end user, and region. The product market has been further segmented into the corresponding instruments, consumables, services, and software. The market value may vary from 5-7%, as the data has been collected from different sources at the regional and country levels.
BIS Related Studies
In vitro diagnostics are tests that can detect diseases, conditions, or infections.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.In Vitro Diagnostic (IVD) tests are a subset of medical devices.
In vitro diagnostic tests are used for in vitro examination of specimens derived from the human body to provide information for screening, diagnosis, or treatment monitoring purposes.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-in-vitro-diagnostic-s-2019-2024-708According to this study, over the next five years the In Vitro Diagnostic (IVD) Products market will register a 6.8% CAGR in terms of revenue, the global market size will reach US$ 91480 million by 2024, from US$ 65820 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in In Vitro Diagnostic (IVD) Products business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Diagnostic (IVD) Products market by product type, application, key manufacturers and key regions and countries.This study considers the In Vitro Diagnostic (IVD) Products value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.Immuno DiagnosticsChemistry DiagnosticsMolecular DiagnosticsPOCTOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.HospitalsLaboratoryOtherThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.The key manufacturers covered in this report: Breakdown data in in Chapter 3.RocheAbbottDanaherSiemens HealthineersThermo Fisher ScientificSysmexBiomerieuxOrtho Clinical DiagnosticsBecton DickinsonBio-Rad LaboratoriesHologicJohnson and JohnsonQiagenMyriad GeneticsWondfoKHBDAAN GeneLeadman BiochemistryMindrayBioSinoIn addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole.
It also analyzes key emerging trends and their impact on present and future development.Research objectivesTo study and analyze the global In Vitro Diagnostic (IVD) Products consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of In Vitro Diagnostic (IVD) Products market by identifying its various subsegments.Focuses on the key global In Vitro Diagnostic (IVD) Products manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the In Vitro Diagnostic (IVD) Products with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of In Vitro Diagnostic (IVD) Products submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-in-vitro-diagnostic-s-2019-2024-708Table of content2019–2024 Global In Vitro Diagnostic (IVD) Products Consumption Market Report1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global In Vitro Diagnostic (IVD) Products Consumption 2014–20242.1.2 In Vitro Diagnostic (IVD) Products Consumption CAGR by Region2.2 In Vitro Diagnostic (IVD) Products Segment by Type2.2.1 Immuno Diagnostics2.2.2 Chemistry Diagnostics2.2.3 Molecular Diagnostics2.2.4 POCT2.2.5 Other2.3 In Vitro Diagnostic (IVD) Products Consumption by Type2.3.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Type (2014–2019)2.3.2 Global In Vitro Diagnostic (IVD) Products Revenue and Market Share by Type (2014–2019)2.3.3 Global In Vitro Diagnostic (IVD) Products Sale Price by Type (2014–2019)2.4 In Vitro Diagnostic (IVD) Products Segment by Application2.4.1 Hospitals2.4.2 Laboratory2.4.3 Other2.5 In Vitro Diagnostic (IVD) Products Consumption by Application2.5.1 Global In Vitro Diagnostic (IVD) Products Consumption Market Share by Application (2014–2019)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
According to the latest report by Renub Research, titled "Japan In Vitro Diagnostics (IVD) Market, By Diagnostics, Companies, Reimbursements, Porter's Model, Growth Drivers, Opportunities Challenges" Japan is facing the problem of the ageing population as it has a large population of people more than 65 years of age.
All of these diseases with the help of IVD test, conditions can be detected early, which leads to early intervention, thus improving patient outcomes, saving lives, and the cost of costly late-stage care.
Increase in the number of IVD laboratories around Japan is enabling patients to get better diagnostic facilities.
According to Renub Research, Japan In Vitro Diagnostic Market is forecasted to be USD 4.43 Billion by 2026.Besides, growth in adoption of genetic testing, point-of-care testing, molecular diagnostics, Polymerase Chain Reaction (PCR), personalized medicine and Next-Generation Sequencing (NGS) is expected to drive the growth of the in vitro diagnostics industry in Japan during the forecast period.
Japan is being considered to have one of the robust clinical laboratories globally.COVID-19 Impact on Japan IVD MarketThe demand for in-vitro diagnostic products is expected to grow in Japan, due to the COVID-19 pandemic is likely to increase due to factors such as growth in consumer demand for PCR, NGS, serology-based rapid-test products, the supportive regulatory environment for drug creation & marketing and a sharp increase in target patient population.Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=japan-in-vitro-diagnostics-market-p.phpMarket Summary:By Diagnostics: This research report has covered the market and market share of Self Monitoring of Blood Glucose (SMBG), Tumor Marker, Infectious Disease, Urine & Feces, Hematology, Immunology, Microbiology, Clinical Chemistry, Pathology and Genetic Testing.By Companies: This research report has covered Company Overview, Recent Development or Strategy, and Revenue analysis for Becton Dickinson, Biomerieux, Abbott Laboratories, Roche Diagnostics, and Danaher Corporation.About Company:Renub Research is a Market Research and Consulting Company.
We provide wide range of business research solutions that helps companies in making better business decisions.
